Skip to main content

For urgent surgical problems, please contact the nearest hospital emergency department.

Thyroid Nodule

Typical recovery: Thyroid-nodule assessment is usually outpatient. Ultrasound requires no recovery time. After fine-needle aspiration, most people resume normal activity immediately or the same day, although mild tenderness or bruising may last for one or two days.

Key points

  • Most thyroid nodules are benign and many do not require treatment.
  • A normal thyroid-function test does not prove that a thyroid nodule is benign; most thyroid cancers occur in patients with normal thyroid hormone levels.
  • Thyroid ultrasound is the central imaging test for assessing a thyroid nodule and should also assess the relevant cervical lymph nodes.
  • Ultrasound features and nodule size are considered together when deciding whether FNAC is needed. Size alone should not determine biopsy.
  • Recognised systems such as ACR TI-RADS or EU-TIRADS help standardise ultrasound risk assessment.
  • If TSH is low, thyroid scintigraphy may identify a hyperfunctioning or autonomous nodule and can change the diagnostic pathway.
  • FNAC is usually performed under ultrasound guidance and is a safe outpatient procedure.
  • The Bethesda system classifies thyroid cytology into six diagnostic categories ranging from non-diagnostic to malignant and helps guide the next step in management.
  • A benign FNAC does not always mean no further follow-up is required. Follow-up depends on ultrasound risk, size, symptoms and whether the clinical, ultrasound and cytological findings agree.
  • Indeterminate cytology does not automatically mean cancer. Repeat FNAC, molecular testing, surveillance or diagnostic lobectomy may be appropriate depending on the individual risk.
  • Core-needle biopsy is not normally the first-line biopsy for a thyroid nodule but can be useful in selected situations when FNAC remains non-diagnostic or another specific diagnosis is suspected.
  • Thyroid-hormone suppression treatment is not routinely recommended simply to shrink thyroid nodules in a patient with normal thyroid function.
  • Selected benign symptomatic cystic nodules can be treated with ethanol ablation, and selected solid benign symptomatic nodules may be suitable for thermal ablation in centres with appropriate expertise.
  • Surgery is not required for every thyroid nodule. The decision should balance cancer risk, symptoms, thyroid function, available alternatives and patient preference.

Overview

A thyroid nodule is a discrete lump within the thyroid gland. Thyroid nodules are very common and most are benign. Many are discovered incidentally on ultrasound, CT or other imaging and cause no symptoms. The main purpose of assessment is to identify the relatively small proportion that may represent thyroid cancer, recognise nodules that produce excess thyroid hormone, and determine whether a large or growing nodule is causing pressure symptoms. Evaluation usually includes a clinical history and neck examination, thyroid-stimulating hormone (TSH) testing and a dedicated thyroid and neck ultrasound. Fine-needle aspiration cytology (FNAC) is not required for every nodule; the decision is based on ultrasound risk features, nodule size and the clinical context. Cytology is reported using a standard system such as the Bethesda classification and is interpreted together with the ultrasound findings rather than in isolation. Most benign nodules can be observed. Surgery is considered when malignancy is diagnosed or strongly suspected, when an indeterminate nodule carries sufficient concern, when a benign nodule causes significant pressure or cosmetic symptoms, or in selected hyperfunctioning nodules. The extent of any thyroid surgery is individualised and is covered separately in the Thyroidectomy guide.

Signs & symptoms

  • Most thyroid nodules cause no symptoms and are discovered incidentally during examination or imaging.
  • A visible or palpable lump in the front or lower part of the neck.
  • A nodule or thyroid swelling that appears to be increasing in size.
  • Pressure, tightness or a sensation of fullness in the neck from a large nodule or multinodular goitre.
  • Difficulty swallowing when a large thyroid nodule or goitre compresses the oesophagus.
  • Shortness of breath, particularly when lying down, if a large thyroid swelling narrows or displaces the airway.
  • Persistent unexplained hoarseness or voice change, which requires assessment because involvement of the recurrent laryngeal nerve is a concerning feature.
  • A new or enlarging lymph node in the neck associated with a thyroid nodule.
  • Palpitations, tremor, heat intolerance, weight loss or other symptoms of hyperthyroidism when a nodule is autonomously producing thyroid hormone.
  • Sudden pain and rapid enlargement can occasionally occur because of bleeding into a thyroid nodule or cyst.

How assessment and treatment are planned

  1. 1

    Take a focused history including duration and growth of the swelling, pressure symptoms, voice change, previous neck irradiation, family history of thyroid cancer and symptoms of thyroid dysfunction.

  2. 2

    Examine the thyroid and cervical lymph-node areas, noting nodule size, consistency, mobility and any clinically suspicious lymph nodes.

  3. 3

    Check thyroid function, particularly serum TSH, with additional thyroid-hormone testing when indicated.

  4. 4

    Perform a dedicated thyroid ultrasound to characterise the nodule and evaluate the cervical lymph nodes.

  5. 5

    Use a recognised ultrasound risk-stratification system such as ACR TI-RADS or EU-TIRADS to describe the nodule and estimate its level of suspicion.

  6. 6

    If TSH is suppressed or below the reference range, consider thyroid scintigraphy to determine whether the nodule is hyperfunctioning. A clearly autonomous or 'hot' nodule is managed differently from a non-functioning nodule.

  7. 7

    Decide whether FNAC is required using the combination of ultrasound risk pattern, nodule size, clinical risk factors and patient preference rather than size alone.

  8. 8

    When biopsy is indicated, perform ultrasound-guided fine-needle aspiration and report the cytology using the Bethesda system or another recognised standardised system.

  9. 9

    Correlate the cytology result with the ultrasound appearance. A benign cytology result that does not fit a highly suspicious ultrasound pattern requires reassessment rather than automatic reassurance.

  10. 10

    For non-diagnostic or selected indeterminate cytology, consider repeat FNAC, further imaging review, molecular testing where available, surveillance or diagnostic surgery according to the level of risk.

  11. 11

    Plan surveillance for nodules that are benign or below biopsy thresholds, with the interval determined by their ultrasound risk category, size and clinical course.

  12. 12

    Discuss surgery when cytology is malignant or strongly suspicious, when an indeterminate nodule warrants diagnostic excision, or when a benign nodule causes significant pressure, progressive growth or other troublesome symptoms.

Preparation

  • Bring all previous thyroid ultrasound reports and, if possible, the original images for comparison.
  • Bring previous FNAC, cytology, molecular-test or thyroid pathology reports.
  • Bring recent thyroid-function tests and other relevant blood-test results.
  • Tell the clinician about previous head or neck irradiation, particularly during childhood or adolescence.
  • Mention any family history of thyroid cancer, medullary thyroid cancer or inherited endocrine tumour syndromes.
  • Tell the clinician about previous thyroid, parathyroid or other neck surgery.
  • Report any existing hoarseness, voice fatigue, swallowing difficulty or breathing symptoms.
  • Bring a complete medication list, particularly anticoagulants and antiplatelet medicines if FNAC may be performed.
  • Do not stop blood-thinning medication on your own; medication management around FNAC should be individualised.
  • If the nodule was discovered incidentally on CT, MRI or PET imaging, bring that report as it may contain clinically relevant information.

Recovery and aftercare

  • No recovery period is required after thyroid ultrasound.
  • After FNAC, mild local tenderness or a small bruise is common and usually settles within a day or two.
  • A small dressing may be applied after FNAC and can usually be removed according to the instructions given by the treating team.
  • Use simple pain relief if required and if medically suitable.
  • Seek medical review for rapidly increasing neck swelling, persistent significant bleeding, marked redness, fever or increasing pain after biopsy.
  • Make sure the cytology result is reviewed together with the ultrasound findings rather than interpreting the pathology report in isolation.
  • If the nodule is being observed, attend the recommended clinical and ultrasound follow-up rather than arranging frequent scans without a defined reason.
  • Return earlier than the scheduled follow-up if the nodule enlarges noticeably or new pressure, voice or swallowing symptoms develop.
  • If cytology is indeterminate, discuss the actual estimated risk and the available options before assuming that surgery is mandatory.
  • If surgery is advised, the type and extent of surgery should be discussed separately because many patients require only thyroid lobectomy rather than automatic total thyroidectomy.

Risks and possible complications

  • Failure to investigate an appropriately suspicious nodule can delay diagnosis of thyroid cancer.
  • Ultrasound can identify many very small nodules that would never cause harm, creating a risk of over-investigation and overdiagnosis if risk-based criteria are not used.
  • FNAC can occasionally be non-diagnostic and may need to be repeated.
  • Indeterminate cytology can create uncertainty and may require repeat biopsy, molecular testing, surveillance or diagnostic surgery.
  • A benign FNAC has a low false-negative rate, but clinically important ultrasound-cytology discordance should not be ignored.
  • FNAC commonly causes only minor discomfort or bruising; significant bleeding is uncommon.
  • Infection after thyroid FNAC is very rare.
  • Benign nodules can enlarge and cause pressure or cosmetic symptoms even when they are not cancerous.
  • Autonomous thyroid nodules can produce excess thyroid hormone and cause hyperthyroidism.
  • Unnecessary surgery exposes a patient to thyroidectomy-related risks when a nodule could safely have been observed, which is why risk-adapted assessment is important.

When to arrange prompt medical assessment

  • A newly discovered thyroid lump or neck swelling that has not previously been assessed.
  • A thyroid nodule that appears to be enlarging or has noticeably changed in character.
  • Persistent unexplained hoarseness or voice change associated with a thyroid swelling.
  • Progressive difficulty swallowing or increasing pressure or tightness in the neck.
  • A new enlarged or hard lymph node in the neck, particularly when associated with a thyroid nodule.
  • Symptoms of possible hyperthyroidism such as persistent palpitations, tremor, heat intolerance or unexplained weight loss.
  • A previously benign nodule that develops new suspicious ultrasound features or significant growth during follow-up.

When to go to an emergency department now

  • Rapid neck swelling associated with difficulty breathing, noisy breathing or inability to swallow normally.
  • Sudden severe swelling or pain in a known thyroid nodule with significant breathing or swallowing difficulty, which may indicate acute haemorrhage into the nodule.
  • Severe breathlessness or stridor caused by a large thyroid swelling.

Myth vs fact

Frequently asked questions

Sources

Medically reviewed by Dr. Shams Alam Mohammed Tahir, MBBS, MS (General Surgery). Last reviewed 2026-09-17.

WhatsApp